Orthotopic heart transplant versus left ventricular assist device: A national comparison of cost and survival
Authors:
- Castigliano M. BhamidipatiCBCastigliano M. Bhamidipati
- Matthew L. StoneMSMatthew L. Stone
- Gorav AilawadiGAGorav Ailawadi
- Irving L. KronIKIrving L. Kron
- John A. KernJKJohn A. Kern
- 1 February 2013
- journal article
- research article
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 145 (2) , 566-574
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (T32: HL007849)
This publication has 15 references indexed in Scilit:
- Forecasting the Future of Cardiovascular Disease in the United StatesCirculation, 2011
- Advanced Heart Failure Treated with Continuous-Flow Left Ventricular Assist DeviceNew England Journal of Medicine, 2009
- Long-term Outcomes and Costs of Ventricular Assist Devices Among Medicare BeneficiariesJAMA, 2008
- REMATCH and Beyond: The Cost of Treating Heart Failure Using an Implantable Left Ventricular Assist DeviceSeminars in Cardiothoracic and Vascular Anesthesia, 2006
- Hospital Costs for Left Ventricular Assist Devices for Destination Therapy: Lower Costs for Implantation in the Post-REMATCH EraThe Journal of Heart and Lung Transplantation, 2006
- Left Ventricular Assist Devices as Permanent Heart Failure TherapyAnnals of Surgery, 2003
- Long-Term Use of a Left Ventricular Assist Device for End-Stage Heart FailureNew England Journal of Medicine, 2001
- The economics of heart transplantation.Circulation, 1987
- Medicare program; solicitation of hospitals and medical centers to participate in a study of heart transplants: Health Care Financing Administration. Notice.1981
- Heart Transplants: To Pay or Not to PayScience, 1980